Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia.
Bussy A, Levy JP, Best T, Patel R, Cupo L, Van Langenhove T, Nielsen JE, Pijnenburg Y, Waldö ML, Remes AM, Schroeter ML, Santana I, Pasquier F, Otto M, Danek A, Levin J, Le Ber I, Vandenberghe R, Synofzik M, Moreno F, de Mendonça A, Sanchez-Valle R, Laforce R, Langheinrich T, Gerhard A, Graff C, Butler CR, Sorbi S, Jiskoot L, Seelaar H, van Swieten JC, Finger E, Tartaglia MC, Masellis M, Tiraboschi P, Galimberti D, Borroni B, Rowe JB, Bocchetta M, Rohrer JD, Devenyi GA, Chakravarty MM, Ducharme S; GENetic Frontotemporal dementia Initiative (GENFI). Bussy A, et al. Among authors: tiraboschi p. Hum Brain Mapp. 2023 May;44(7):2684-2700. doi: 10.1002/hbm.26220. Epub 2023 Mar 9. Hum Brain Mapp. 2023. PMID: 36895129 Free PMC article.
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
IST-3 collaborative group; Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A. IST-3 collaborative group, et al. Lancet. 2012 Jun 23;379(9834):2352-63. doi: 10.1016/S0140-6736(12)60768-5. Epub 2012 May 23. Lancet. 2012. PMID: 22632908 Free PMC article. Clinical Trial.
Pergolide effect on cognitive functions in early-mild Parkinson's disease.
Brusa L, Tiraboschi P, Koch G, Peppe A, Pierantozzi M, Ruggieri S, Stanzione P. Brusa L, et al. Among authors: tiraboschi p. J Neural Transm (Vienna). 2005 Feb;112(2):231-7. doi: 10.1007/s00702-004-0193-0. Epub 2004 Sep 10. J Neural Transm (Vienna). 2005. PMID: 15365788 Clinical Trial.
Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI.
Massa F, Arnaldi D, De Cesari F, Girtler N, Brugnolo A, Grazzini M, Bauckneht M, Meli R, Morbelli S, Pardini M, Sambuceti G, De Carli F, Tiraboschi P, Nobili F. Massa F, et al. Among authors: tiraboschi p. Neurobiol Aging. 2019 Apr;76:9-17. doi: 10.1016/j.neurobiolaging.2018.12.001. Epub 2018 Dec 13. Neurobiol Aging. 2019. PMID: 30611093
[Fluoxetine].
Tiraboschi P, Spagnoli A. Tiraboschi P, et al. Medicina (Firenze). 1989 Apr-Jun;9(2):233-5. Medicina (Firenze). 1989. PMID: 2682124 Review. Italian. No abstract available.
[Mianserin].
Tiraboschi P. Tiraboschi P. Medicina (Firenze). 1988 Jul-Sep;8(3):351-3. Medicina (Firenze). 1988. PMID: 3068469 Review. Italian. No abstract available.
167 results